Hyperglycemia produces oxidative stress, upregulating endothelial NOX1/O2•−, but not NOX2, mediated reduction in NO bioavailability, eNOS uncoupling and endothelial dysfunction, and generation of pro-inflammatory/pro-fibrotic factors [152]. Here, CYBB is linked to endothelial dysfunction.